Ardea Biosciences' Acquisition

Ardea Biosciences was acquired by AstraZeneca on April 23, 2012.

Ardea Biosciences is focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV).…

Articles about Ardea Biosciences' Acquisition: